Striders Impex IPO...
20 Feb, 2026
Sheel Biotech IPO
Sheel Biotech IPO is a book-build issue of INR 34.02 crores. The issue consists entirely of a fresh issue of 0.54 crore shares. The lot size for an application is 2,000 shares and the price band is set at INR 59 to INR 63 per share. The minimum amount required for investment by an individual investor is INR 2,52,000 (4,000 shares). Sheel Biotech IPO will list on NSE SME, with a tentative listing date fixed as October 8, 2025. The IPO is expected to be finalized on October 8, 2025.
Company Background
Sheel Biotech Ltd. was founded in 1991 and operates in biotechnology, agriculture, and horticulture. The company specializes in plant tissue culture, bio-fertilizers, and organic farming practices. Headquartered in New Delhi, Sheel Biotech has regional offices across India and a strong distribution network. The company is managed by industry professionals with decades of expertise. Their mission is to deliver sustainable, eco-friendly, and affordable solutions to promote healthier farming methods and environmental care.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Sheel Biotech IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Sheel Biotech IPO Details
| Detail | Description |
|---|---|
| IPO Date | September 30, 2025 to October 3, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | ₹59 to ₹63 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 54,00,000 shares (aggregating up to ₹34.02 Cr) |
| Reserved for Market Maker | 2,72,000 shares (aggregating up to ₹1.71 Cr) |
| Net Offered to Public | 51,28,000 shares (aggregating up to ₹32.31 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,49,52,550 shares |
| Share Holding Post Issue | 2,03,52,550 shares |
Sheel Biotech IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Tue, Sep 30, 2025 |
| IPO Close Date | Fri, Oct 3, 2025 |
| Tentative Allotment | Mon, Oct 6, 2025 |
| Initiation of Refunds | Tue, Oct 7, 2025 |
| Credit of Shares to Demat | Tue, Oct 7, 2025 |
| Tentative Listing Date | Wed, Oct 8, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Oct 3, 2025 |
Sheel Biotech IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 4,000 | ₹2,52,000 |
| Individual investors (Retail) (Max) | 2 | 4,000 | ₹2,52,000 |
| S-HNI (Min) | 3 | 6,000 | ₹3,78,000 |
| S-HNI (Max) | 7 | 14,000 | ₹8,82,000 |
| B-HNI (Min) | 8 | 16,000 | ₹10,08,000 |
Sheel Biotech IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Promoter Holding Pre Issue | 96.99% |
| Promoter Holding Post Issue | 71.26% |
Competitive Strength:
- • Extensive experience in plant tissue culture, leveraging government initiatives.
- • Advanced greenhouse technology and FPO management experience, which provide great results in outcomes.
Sheel Biotech IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 May 2024 | 105.98 | 3.99 | 0.48 | 73.21 | - | 25.22 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2024 | 105.95 | 92.55 | 10.51 | 72.73 | - | 23.54 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 93.89 | 80.19 | 5.08 | 63.54 | - | 19.17 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2022 | 93.08 | 71.07 | 4.51 | 59.75 | - | 23.58 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 13.59% |
| ROCE | 16.34% |
| Debt/Equity | 0.32 |
| RoNW | 13.59% |
| PAT Margin | 14.71% |
| Price to Book Value | 1.26 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 7.03 | 1.43 |
| P/E (x) | 8.96 | 44.07 |
Conclusion
Sheel Biotech IPO offers investors a chance to participate in a company that is deeply focused on sustainable agriculture and biotechnology. With expertise in tissue culture and organic farming, the company is well-positioned to benefit from the rising demand for organic and eco-friendly products. Investors may find this IPO attractive due to its focus on innovation, environmental sustainability, and consistent growth in revenue from the agriculture and biotech sectors.
RHP:
View RHPDRHP:
View DRHPRead more :
